z-logo
open-access-imgOpen Access
Comparison of Outcomes between Hamstring Autograft and Synthetic (LARS) ACL Reconstructions
Author(s) -
Woods K.R.,
McGrath T.M.,
Waddington G.,
Scarvell J.M.,
Ball N.,
Adams R.,
Creer R.,
Smith D.
Publication year - 2017
Publication title -
orthopaedic journal of sports medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 35
ISSN - 2325-9671
DOI - 10.1177/2325967117s00203
Subject(s) - hamstring , medicine , rehabilitation , surgery , prospective cohort study , knee joint , physical therapy
Objectives: This study compared the short term (24 month) clinical outcomes in a prospective, comparative case series of participant selected hamstring autograft and synthetic (LARS) ACL reconstructions.Methods: 64 ACL reconstructed participants (32 hamstring,32 LARS), completed a “goal-oriented” rehabilitation protocol. They were assessed for joint laxity (KT1000), clinical outcome (IKDC Knee Examination) and activity (Tegner Activity Scale-TAS) pre-operatively and at 12,16,20 and 24 weeks, and at 12 and 24 months post-operatively.Results: KT 1000 results did not differ significantly between the 2 treatment groups at 24 months. Differences were noted in joint laxity measurements between the 2 groups at varying time points. The LARS group had immediate stability of the joint at 12 weeks followed by a gradual increase in laxity over the follow-up period, while the hamstring group showed an increase in laxity up to 16-20 weeks, followed by a gradual decrease over the follow-up period. The LARS group had significantly higher TAS scores in the early post-operative period, but there was no significant difference between the 2 groups at 12 months and beyond. At 24 months, 32 of the hamstring group and 30 of the LARS group achieved IKDC Scores “A” or “B”. There were 5 reported graft failures (15.6%) in the LARS group between 7 and 22 months post-op, and none in the hamstring group.Conclusion: ACL reconstruction using synthetic (LARS) grafts produced earlier return of some activities compared to autograft reconstructions, but this difference was no longer evident by 12 months post-op. When the substantially differing failure rates are taken into consideration, this early benefit does not appear to justify their use in place of autografts for ACL reconstruction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom